Compensation Agreements in the Biotechnology Industry

1,324 Contracts & Agreements

Browse by Company

2seventy bio, Inc. (1 contract)
4D Molecular Therapeutics Inc (1)
89bio, Inc. (3)
AbbVie Inc. (3)
ACADIA PHARMACEUTICALS INC (5)
Acorda Therapeutics (1)
Acumen Pharmaceuticals, Inc. (2)
Adagio Therapeutics, Inc. (2)
Adamas Pharmaceuticals Inc (4)
ADMA BIOLOGICS, INC. (1)
ADURO BIOTECH, INC. (4)
Adverum Biotechnologies, Inc. (7)
Aerovate Therapeutics, Inc. (2)
AGENUS INC (4)
AgeX Therapeutics, Inc. (2)
Aimmune Therapeutics, Inc. (2)
AKCEA THERAPEUTICS, INC. (3)
Akebia Therapeutics, Inc. (6)
Akero Therapeutics, Inc. (4)
Akouos, Inc. (1)
ALBIREO PHARMA, INC. (11)
Alector, Inc. (4)
Alexion Pharmaceuticals (1)
Aligos Therapeutics, Inc. (2)
Allakos Inc. (6)
Allena Pharmaceuticals, Inc. (4)
Allogene Therapeutics, Inc. (5)
ALNYLAM PHARMACEUTICALS, INC. (2)
ALPINE IMMUNE SCIENCES, INC. (5)
Altimmune, Inc. (2)
ALX ONCOLOGY HOLDINGS INC (2)
AMARILLO BIOSCIENCES INC (1)
AMARIN CORP PLC (1)
Amgen Inc. (14)
Amplitude Healthcare Acquisition Corp (2)
Anchiano Therapeutics Ltd. (1)
Anika Therapeutics (2)
Annexon, Inc. (4)
Apellis Pharmaceuticals, Inc. (3)
Applied Molecular Transport Inc. (1)
Aptinyx Inc. (3)
Aravive, Inc. (3)
Arcellx, Inc. (1)
Arcus Biosciences, Inc. (7)
Arcutis Biotherapeutics, Inc. (1)
ARDELYX, INC. (4)
ARENA PHARMACEUTICALS INC (14)
ARROWHEAD PHARMACEUTICALS, INC. (1)
Arsanis, Inc. (1)
Artiva Biotherapeutics, Inc. (2)
ARYA Sciences Acquisition Corp II (5)
Atreca, Inc. (1)
aTYR PHARMA INC (1)
Aura Biosciences, Inc. (2)
Avid Bioservices, Inc. (3)
Avidity Biosciences, Inc. (5)
Avita Therapeutics, Inc. (1)
AVROBIO, Inc. (1)
Axovant Sciences Ltd. (2)
Ayala Pharmaceuticals, Inc. (1)
AZIYO BIOLOGICS, INC. (1)
BCTG Acquisition Corp. (4)
Beam Therapeutics Inc. (6)
BeiGene, Ltd. (7)
BELLICUM PHARMACEUTICALS, INC (8)
BICYCLE THERAPEUTICS Ltd (5)
BioAtla, Inc. (2)
BIOCEPT INC (1)
BIOMARIN PHARMACEUTICAL INC (11)
Biomea Fusion, Inc. (1)
Biostage, Inc. (2)
BioXcel Therapeutics, Inc. (1)
Black Diamond Therapeutics, Inc. (3)
bluebird bio, Inc. (2)
Bone Biologics Corp (1)
BRAINSTORM CELL THERAPEUTICS INC. (6)
BriaCell Therapeutics Corp. (2)
BridgeBio Pharma, Inc. (2)
BullFrog AI Holdings, Inc. (1)
Cabaletta Bio, Inc. (4)
CALADRIUS BIOSCIENCES, INC. (9)
Calyxt, Inc. (1)
CAPRICOR THERAPEUTICS, INC. (1)
CareDx, Inc. (6)
Caribou Biosciences, Inc. (17)
CASTLE BIOSCIENCES INC (8)
CATABASIS PHARMACEUTICALS INC (2)
CATALYST BIOSCIENCES, INC. (3)
Cellectar Biosciences, Inc. (1)
Cellular Biomedicine Group, Inc. (1)
Checkmate Pharmaceuticals, Inc. (1)
Checkpoint Therapeutics, Inc. (3)
Chelsea Worldwide Inc. (1)
ChemoCentryx, Inc. (7)
CHIMERIX INC (7)
Cidara Therapeutics, Inc. (4)
CLEVELAND BIOLABS INC (2)
Codiak BioSciences, Inc. (2)
CohBar, Inc. (1)
Conatus Pharmaceuticals Inc. (3)
CONCERT PHARMACEUTICALS, INC. (8)
Constellation Alpha Capital Corp. (2)
CONSTELLATION PHARMACEUTICALS INC (1)
CONTRAFECT Corp (2)
Corbus Pharmaceuticals Holdings, Inc. (2)
Cortexyme, Inc. (1)
Crinetics Pharmaceuticals, Inc. (2)
CTI BIOPHARMA CORP (12)
Cue Biopharma, Inc. (4)
Cullinan Oncology, LLC (2)
CURIS INC (6)
Cyclerion Therapeutics, Inc. (2)
CytoDyn Inc. (4)
Cytokinetics, Incorporated (7)
CYTORI THERAPEUTICS, INC. (1)
Deciphera Pharmaceuticals, Inc. (4)
Denali Therapeutics Inc. (5)
Design Therapeutics, Inc. (2)
Dynamics Special Purpose Corp. (1)
DYNAVAX TECHNOLOGIES CORP (7)
Eagle Pharmaceuticals, Inc. (1)
Editas Medicine, Inc. (3)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (6)
Emergent BioSolutions Inc. (3)
Entasis Therapeutics Holdings Inc. (4)
Entrada Therapeutics, Inc. (3)
ENZON PHARMACEUTICALS, INC. (6)
Epizyme, Inc. (5)
Equillium, Inc. (6)
Erasca, Inc. (2)
Esperion Therapeutics, Inc. (2)
Evelo Biosciences, Inc. (4)
EXACT SCIENCES CORP (16)
Exelixis (36)
FATE THERAPEUTICS INC (6)
FIBROGEN INC (8)
FIVE PRIME THERAPEUTICS INC (1)
Flex Pharma, Inc. (3)
Flexion Therapeutics Inc (7)
Forma Therapeutics Holdings, Inc., (4)
Frequency Therapeutics, Inc. (2)
G1 Therapeutics, Inc. (4)
Galecto Inc. (5)
Galera Therapeutics, Inc. (4)
Gamida Cell Ltd. (1)
Gemphire Therapeutics Inc. (3)
GENELUX CORP (2)
Generation Bio Co. (2)
GENEREX BIOTECHNOLOGY CORP (3)
Genprex, Inc. (4)
GeoVax Labs, Inc. (2)
GERON CORP (11)
Gilead Sciences (4)
Global Blood Therapeutics, Inc. (4)
GLYCOMIMETICS INC (7)
Gossamer Bio, Inc. (5)
Grail, Inc. (2)
Graphite Bio, Inc. (3)
Gritstone Oncology, Inc. (2)
GTX INC (26)
GX Acquisition Corp. (1)
HALOZYME THERAPEUTICS INC (2)
HARBOR DIVERSIFIED, INC. (1)
Harpoon Therapeutics, Inc. (3)
HCW Biologics Inc. (1)
HilleVax, Inc. (2)
HISTOGENICS CORP (2)
Homology Medicines, Inc. (4)
HUMANIGEN, INC (2)
Icosavax, Inc. (1)
IDEAYA Biosciences, Inc. (2)
IDERA PHARMACEUTICALS, INC. (6)
IGM Biosciences, Inc. (6)
Imago BioSciences, Inc. (2)
Immix Biopharma, Inc. (1)
IMMUCELL CORP (1)
Immuneering Corp (5)
ImmunoCellular Therapeutics, Ltd. (2)
IMMUNOGEN INC (10)
Immunome Inc. (4)
IN8BIO, INC. (9)
Inhibrx, Inc. (1)
Inozyme Pharma, Inc. (2)
Inspyr Therapeutics, Inc. (5)
Instil Bio, Inc. (1)
Intec Parent Inc. (1)
Intec Pharma Ltd. (2)
Intellia Therapeutics, Inc. (5)
INTERCEPT PHARMACEUTICALS, INC. (4)
INTREXON CORP (1)
Intrinsic Medicine, Inc. (1)
IONIS PHARMACEUTICALS INC (3)
IOVANCE BIOTHERAPEUTICS, INC. (1)
IRONWOOD PHARMACEUTICALS INC (5)
Janux Therapeutics, Inc. (3)
Jounce Therapeutics, Inc. (7)
KalVista Pharmaceuticals, Inc. (2)
Karyopharm Therapeutics Inc. (3)
KBL MERGER CORP. IV (1)
Keros Therapeutics, Inc. (2)
Kezar Life Sciences, Inc. (4)
Kiniksa Pharmaceuticals, Ltd. (2)
Kinnate Biopharma Inc. (2)
Kodiak Sciences Inc. (2)
Kronos Bio, Inc. (3)
Kura Oncology, Inc. (4)
Kymera Therapeutics, Inc. (4)
Leisure Acquisition Corp. (1)
LEXICON PHARMACEUTICALS, INC. (12)
LianBio (1)
Ligand Pharmaceuticals Incorporated (1)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (1)
Locust Walk Acquisition Corp. (5)
Lyell Immunopharma, Inc. (3)
MADRIGAL PHARMACEUTICALS, INC. (7)
MANNKIND CORP (3)
MATEON THERAPEUTICS INC (7)
Matinas BioPharma Holdings, Inc. (2)
MEI Pharma, Inc. (1)
MeiraGTx Holdings plc (7)
MERRIMACK PHARMACEUTICALS INC (1)
Mersana Therapeutics, Inc. (2)
Merus N.V. (2)
Metacrine, Inc. (3)
Millendo Therapeutics, Inc. (5)
MiMedx Group, Inc. (7)
Minerva Neurosciences, Inc. (3)
MIRAGEN THERAPEUTICS, INC. (1)
Mirati Therapeutics, Inc. (10)
Mirum Pharmaceuticals, Inc. (4)
Moderna, Inc. (4)
Molecular Templates, Inc. (4)
Momenta Pharmaceuticals, Inc. (13)
Myovant Sciences Ltd. (4)
Myriad Genetics, Inc. (12)
NantKwest, Inc. (1)
Natera, Inc. (6)
NEUROTROPE BIOSCIENCE, INC. (2)
Neurotrope, Inc. (1)
NexImmune, Inc. (2)
NextCure, Inc. (2)
Nkarta, Inc. (4)
NORTHWEST BIOTHERAPEUTICS INC (1)
NTN BUZZTIME INC (2)
Nuvalent, Inc. (3)
Ohr Pharmaceutical Inc (3)
Olema Pharmaceuticals, Inc. (3)
Omega Therapeutics, Inc. (2)
OPGEN INC (3)
Ophthotech Corp. (4)
Oric Pharmaceuticals, Inc. (3)
Outlook Therapeutics, Inc. (2)
Ovid Therapeutics Inc. (3)
Oyster Point Pharma, Inc. (2)
Passage BIO, Inc. (1)
PDL BIOPHARMA, INC. (1)
PepGen Inc. (3)
PharmaCyte Biotech, Inc. (4)
PhaseBio Pharmaceuticals Inc (5)
PIERIS PHARMACEUTICALS, INC. (7)
PLURISTEM THERAPEUTICS INC (4)
PMV Pharmaceuticals, Inc. (4)
POLARITYTE, INC. (3)
PORTOLA PHARMACEUTICALS INC (7)
Poseida Therapeutics, Inc. (5)
Praxis Precision Medicines, Inc. (4)
PRECISION BIOSCIENCES INC (3)
Prevail Therapeutics Inc. (2)
Progenics Pharmaceuticals, Inc. (2)
Prometheus Biosciences, Inc. (2)
Protagenic Therapeutics, Inc. (1)
PROTEON THERAPEUTICS INC (5)
PROTEOSTASIS THERAPEUTICS, INC. (2)
PUMA BIOTECHNOLOGY, INC. (6)
Pyxis Oncology, Inc. (1)
Radius Health, Inc. (4)
RAPT Therapeutics, Inc. (5)
RECURSION PHARMACEUTICALS, INC. (1)
REGENXBIO Inc. (6)
Regulus Therapeutics Inc. (6)
Relay Therapeutics, Inc. (3)
Reneo Pharmaceuticals, Inc. (3)
RenovoRx, Inc. (6)
Replimune Group, Inc. (1)
Retrophin, Inc. (5)
Revolution Medicines, Inc. (5)
REXAHN PHARMACEUTICALS, INC. (4)
RHYTHM PHARMACEUTICALS, INC. (10)
RIGEL PHARMACEUTICALS INC (4)
RITTER PHARMACEUTICALS INC (1)
ROCKET PHARMACEUTICALS, INC. (1)
Rubius Therapeutics, Inc. (1)
Sage Therapeutics, Inc. (6)
Sana Biotechnology, Inc. (3)
Sarepta Therapeutics, Inc. (1)
Savara Inc (2)
SEATTLE GENETICS INC (2)
SELECTA BIOSCIENCES INC (8)
Sensei Biotherapeutics, Inc. (3)
SERA PROGNOSTICS, INC. (2)
Seres Therapeutics, Inc. (7)
Shattuck Labs, Inc. (2)
Shuttle Pharmaceuticals Holdings, Inc. (1)
Sigilon Therapeutics, Inc. (2)
Silverback Therapeutics, Inc. (4)
Social Capital Suvretta Holdings Corp. III (1)
SOLENO THERAPEUTICS INC (1)
Solid Biosciences Inc. (7)
SOPHIRIS BIO INC. (1)
Sorrento Therapeutics, Inc. (2)
Spero Therapeutics, Inc. (4)
SPHERIX INC (6)
Spring Bank Pharmaceuticals, Inc. (4)
SpringWorks Therapeutics, Inc. (3)
SPRUCE BIOSCIENCES, INC. (4)
SQZ Biotechnologies Co (3)
Stellar Biotechnologies, Inc. (1)
SUNESIS PHARMACEUTICALS INC (8)
Syndax Pharmaceuticals Inc (3)
SYNLOGIC, INC. (4)
Syros Pharmaceuticals, Inc. (2)
T2 Biosystems, Inc. (10)
Talaris Therapeutics, Inc. (3)
Taysha Gene Therapies, Inc. (2)
TENAX THERAPEUTICS, INC. (3)
Tenaya Therapeutics, Inc. (3)
TG THERAPEUTICS, INC. (1)
Tocagen Inc (5)
Tracon Pharmaceuticals, Inc. (8)
Translate Bio, Inc. (3)
TREVENA INC (4)
Turning Point Therapeutics, Inc. (4)
Tyra Biosciences, Inc. (3)
U.S. Stem Cell, Inc. (3)
Ultragenyx Pharmaceutical Inc. (2)
Unity Biotechnology, Inc. (6)
Unum Therapeutics Inc. (3)
UroGen Pharma Ltd. (2)
VACCINEX, INC. (1)
Vaccitech plc (1)
Vaxart, Inc. (2)
Vera Therapeutics, Inc. (2)
Vericel Corp (5)
Vertex Pharmaceuticals Inc (16)
Verve Therapeutics, Inc. (3)
VICAL INC (3)
Viela Bio, Inc. (2)
Vigil Neuroscience, Inc. (3)
Viking Therapeutics, Inc. (5)
Vir Biotechnology, Inc. (3)
VITAL THERAPIES INC (4)
Vor Biopharma Inc. (1)
Xencor Inc (8)
Xilio Therapeutics, Inc. (3)
Y-mAbs Therapeutics, Inc. (2)
Zai Lab Ltd (4)
Zentalis Pharmaceuticals, LLC (5)

Recent Contracts

Director Compensation Policy effective June 5, 2024 (Cue Biopharma, Inc., Filed With SEC on November 14, 2024)
GRAIL, Inc. 2024 Deferred Compensation Plan for Directors (Grail, Inc., Filed With SEC on November 13, 2024)
Non-Employee Director Compensation Policy (as amended August 30, 2024) (IN8BIO, INC., Filed With SEC on November 12, 2024)
IN8BIO, Inc. Non-Employee Director Compensation Policy (IN8BIO, INC., Filed With SEC on November 12, 2024)
Non-Employee Director Compensation Policy of Tectonic Therapeutic, Inc (AVROBIO, Inc., Filed With SEC on November 12, 2024)
Chimerix, Inc. Non-Employee Director Compensation Policy, as amended (CHIMERIX INC, Filed With SEC on November 7, 2024)
BioMarin Pharmaceutical Inc. Summary of Independent Director Compensation (BIOMARIN PHARMACEUTICAL INC, Filed With SEC on October 31, 2024)
OnKure Therapeutics, Inc. Outside Director Compensation Policy (Reneo Pharmaceuticals, Inc., Filed With SEC on October 8, 2024)
Non-Employee Director Compensation Policy (bluebird bio, Inc., Filed With SEC on September 13, 2024)
Second Amendment to Avid Bioservices, Inc. Deferred Compensation Plan (Avid Bioservices, Inc., Filed With SEC on August 29, 2024)
Pyxis Oncology, Inc. Deferred Compensation Plan (Pyxis Oncology, Inc., Filed With SEC on August 14, 2024)
Amended and Restated Outside Director Compensation Policy (SUNESIS PHARMACEUTICALS INC, Filed With SEC on August 14, 2024)
Amended and Restated Non-Employee Director Compensation Policy (Vigil Neuroscience, Inc., Filed With SEC on August 13, 2024)
Praxis Precision Medicines, Inc. Non-Employee Director Compensation Policy (Praxis Precision Medicines, Inc., Filed With SEC on August 13, 2024)
Second Amended and Restated Non-Employee Director Compensation Policy (Entrada Therapeutics, Inc., Filed With SEC on August 13, 2024)
Third Amended and Restated Non-Employee Director Compensation Plan, dated as of June 11, 2024 (REXAHN PHARMACEUTICALS, INC., Filed With SEC on August 13, 2024)
Retention Compensation Agreement between Galecto, Inc. and Garrett Winslow, dated October 19, 2023 (Galecto Inc., Filed With SEC on August 12, 2024)
Non-Employee Director Compensation Program (MeiraGTx Holdings plc, Filed With SEC on August 12, 2024)
Non-Employee Director Compensation Policy (Adverum Biotechnologies, Inc., Filed With SEC on August 12, 2024)
Amended and Restated Non-Employee Director Compensation Policy (Akero Therapeutics, Inc., Filed With SEC on August 9, 2024)
Non-Employee Director Compensation Program, effective as of April 1, 2024 (Vaxart, Inc., Filed With SEC on August 8, 2024)
Non-Employee Director Compensation Policy, as amended on June 20, 2024 (PepGen Inc., Filed With SEC on August 8, 2024)
Amended and Restated Director Compensation Policy (BioAtla, Inc., Filed With SEC on August 8, 2024)
IN8BIO, Inc. Non-Employee Director Compensation Policy (IN8BIO, INC., Filed With SEC on August 8, 2024)
UroGen Pharma Ltd. 2024 Non-Employee Director and Officer Compensation Policy (UroGen Pharma Ltd., Filed With SEC on August 8, 2024)
Seventh Amended and Restated Non-Employee Director Compensation Policy (Intellia Therapeutics, Inc., Filed With SEC on August 8, 2024)
Amended and Restated Non-Employee Director Compensation Policy (Aura Biosciences, Inc., Filed With SEC on August 8, 2024)
Non-Employee Director Compensation Policy (BCTG Acquisition Corp., Filed With SEC on August 7, 2024)
Amended and Restated Non-Employee Director Compensation Policy (Janux Therapeutics, Inc., Filed With SEC on August 7, 2024)
Lyell Immunopharma, Inc. Non-Employee Director Compensation Policy (Lyell Immunopharma, Inc., Filed With SEC on August 7, 2024)
Mirum Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (Mirum Pharmaceuticals, Inc., Filed With SEC on August 7, 2024)
Amended and Restated Non-Employee Director Compensation Policy (Keros Therapeutics, Inc., Filed With SEC on August 7, 2024)
Outside Director Compensation Policy (Allakos Inc., Filed With SEC on August 7, 2024)
Non-Employee Director Compensation Program, effective May 28, 2024 (Omega Therapeutics, Inc., Filed With SEC on August 6, 2024)
Non-Employee Director Compensation Policy (Aligos Therapeutics, Inc., Filed With SEC on August 6, 2024)
Immuneering Corporation Non-Employee Director Compensation Program, as amended (Immuneering Corp, Filed With SEC on August 6, 2024)
Olema Pharmaceuticals, Inc. Amended and Restated Non-Employee Director Compensation Policy (Olema Pharmaceuticals, Inc., Filed With SEC on August 6, 2024)
Amended and Restated Non-Employee Director Compensation Policy (Silverback Therapeutics, Inc., Filed With SEC on August 6, 2024)
Non-Employee Director Compensation Program (RHYTHM PHARMACEUTICALS, INC., Filed With SEC on August 6, 2024)
Non-Employee Director Compensation Policy, as amended effective May 31, 2024 (CASTLE BIOSCIENCES INC, Filed With SEC on August 5, 2024)

Category

Industry

Companies

Contracts

Compensation Agreements in the Biotechnology Industry